These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 3324021

  • 1. Comparison of an estrogen receptor related protein, the ERD5 antigen, with estrogen and progesterone receptors in breast cancer patients.
    Smyth CM, Benn DE, Reeve TS.
    Pathology; 1987 Jul; 19(3):219-22. PubMed ID: 3324021
    [Abstract] [Full Text] [Related]

  • 2. Comparison of enzyme immunoassay with dextran-coated charcoal method in the determination of progesterone receptor in breast cancer cytosols.
    Noguchi S, Miyauchi K, Imaoka S, Koyama H, Iwanaga T.
    Eur J Cancer Clin Oncol; 1988 Nov; 24(11):1715-9. PubMed ID: 3061826
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Estrogen and progesterone receptors and pS2 and ERD5 antigens in gastric carcinomas from the European population.
    Chaubert P, Bouzourene H, Saraga E.
    Mod Pathol; 1996 Mar; 9(3):189-93. PubMed ID: 8685212
    [Abstract] [Full Text] [Related]

  • 5. Comparison of monoclonal antibodies and tritiated ligands for estrogen receptor assays in 241 breast cancer cytosols.
    Goussard J, Lechevrel C, Martin PM, Roussel G.
    Cancer Res; 1986 Aug; 46(8 Suppl):4282s-4287s. PubMed ID: 2425945
    [Abstract] [Full Text] [Related]

  • 6. Sodium molybdate increases the amount of progesterone and estrogen receptor detected in certain human breast cancer cytosols.
    Anderson KM, Phelan J, Marogil M, Hendrickson C, Economou S.
    Steroids; 1980 Mar; 35(3):273-80. PubMed ID: 7189611
    [Abstract] [Full Text] [Related]

  • 7. Estrogen receptor measurement in low-protein breast cancer cytosols. A modified charcoal technique.
    Powell BL, De La Garza M, Clark GM, McGuire WL.
    Breast Cancer Res Treat; 1981 Mar; 1(1):33-5. PubMed ID: 7348563
    [Abstract] [Full Text] [Related]

  • 8. Retinoic acid binding proteins and steroid receptor levels in human breast cancer.
    Mehta RG, Kute TE, Hopkins M, Moon RC.
    Eur J Cancer Clin Oncol; 1982 Mar; 18(3):221-6. PubMed ID: 6284515
    [Abstract] [Full Text] [Related]

  • 9. [Comparison of enzyme immunoassay and tritiated steroid binding assay for estrogen and progesterone receptor in 56 breast cancer cytosols].
    Noguchi S, Miyauchi K, Nishizawa Y, Koyama H.
    Nihon Gan Chiryo Gakkai Shi; 1988 Jun 20; 23(6):1257-64. PubMed ID: 3068322
    [No Abstract] [Full Text] [Related]

  • 10. Immunoglobulin G (IgG) levels in breast tumor cytosols.
    Winsten S, Tabachnick J, Young I.
    Am J Clin Pathol; 1985 Mar 20; 83(3):364-6. PubMed ID: 3976571
    [Abstract] [Full Text] [Related]

  • 11. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
    Allegra JC, Lippman ME, Thompson EB, Simon R, Barlock A, Green L, Huff KK, Do HM, Aitken SC.
    Cancer Res; 1979 May 20; 39(5):1447-54. PubMed ID: 427788
    [Abstract] [Full Text] [Related]

  • 12. Biochemical correlates of morphologic differentiation in human breast cancer.
    Silva JS, Cox CE, Wells SA, Paull D, Dilley WG, McCarty KS, Fetter BF, Glaubitz LC, McCarty KS.
    Surgery; 1982 Sep 20; 92(3):443-9. PubMed ID: 7202259
    [Abstract] [Full Text] [Related]

  • 13. Monoclonal antibody technique for detection of estrogen receptors in human breast cancer: greater sensitivity and more accurate classification of receptor status than the dextran-coated charcoal method.
    Thorpe SM.
    Cancer Res; 1987 Dec 15; 47(24 Pt 1):6572-5. PubMed ID: 2445474
    [Abstract] [Full Text] [Related]

  • 14. Quantitative progesterone receptor expression and efficacy of anti-estrogen therapy in breast cancer.
    Luoh SW, Ramsey B, Park B, Keenan E.
    Breast J; 2014 Dec 15; 20(1):46-52. PubMed ID: 24261828
    [Abstract] [Full Text] [Related]

  • 15. Quantitative enzyme-linked immunosorbent assay for the estrogen-regulated Mr 24,000 protein in human breast tumors: correlation with estrogen and progesterone receptors.
    Adams DJ, McGuire WL.
    Cancer Res; 1985 Jun 15; 45(6):2445-9. PubMed ID: 3886134
    [Abstract] [Full Text] [Related]

  • 16. Comparison of an immunocytochemical assay for progesterone receptor with a biochemical method of measurement and immunocytochemical examination of the relationship between progesterone and estrogen receptors.
    Berger U, Wilson P, Thethi S, McClelland RA, Greene GL, Coombes RC.
    Cancer Res; 1989 Sep 15; 49(18):5176-9. PubMed ID: 2766287
    [Abstract] [Full Text] [Related]

  • 17. Cytosol protein content and prognosis in operable breast cancer. Correlations with steroid hormone receptors and other prognostic factors.
    Søreide JA, Lea OA, Kvinnsland S.
    Breast Cancer Res Treat; 1991 Dec 15; 20(1):25-32. PubMed ID: 1813067
    [Abstract] [Full Text] [Related]

  • 18. ER-D5 antigen in breast cancer.
    Navarro MA, Guardia M, Arranz B, Bonnin MR, Rosel P.
    J Cancer Res Clin Oncol; 1989 Dec 15; 115(3):290-1. PubMed ID: 2753930
    [Abstract] [Full Text] [Related]

  • 19. Steroid receptor measurement in breast cancers: comparison between ligand binding and enzyme-immunoassay in cytosolic and nuclear extracts.
    Luqmani YA, Temmim L, Memon A, Ali MA, Parkar AH.
    Int J Cancer; 1997 May 16; 71(4):526-38. PubMed ID: 9178804
    [Abstract] [Full Text] [Related]

  • 20. Oestrogen receptor, progesterone receptor, pS2, ERD5, HSP27 and cathepsin D in invasive ductal breast carcinomas.
    Hurlimann J, Gebhard S, Gomez F.
    Histopathology; 1993 Sep 16; 23(3):239-48. PubMed ID: 8225242
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.